×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Event Driven
  • RANGELEY CAPITAL, LLC (Data extracted from 13F, 13D, 13G and Form 4)

RANGELEY CAPITAL, LLC

AUM: $196.94 M
13-F Portfolio Value: $115.57 M
Last 13-F Filed: Q3 2025
Concentration in top 10: 41.83%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
DKDELEK US HLDGS INC NEW5.75%206,000$6,647,620-107,000-34.19%$32.2713F
PRTAPROTHENA CORP PLC4.73%560,457$5,470,060-154,910-21.65%$9.7613F
KROSKEROS THERAPEUTICS INC3.54%258,619$4,091,353-26,781-9.38%$15.8213F
ABUSARBUTUS BIOPHARMA CORP3.3%840,000$3,813,600-25,000-2.89%$4.5413F
SEGSEAPORT ENTMT GROUP INC3.05%154,000$3,529,680-4,000-2.53%$22.9213F
SGRYSURGERY PARTNERS INC2.32%124,000$2,683,360-42,060-25.33%$21.6413F
CORZWCORE SCIENTIFIC INC NEW2.11%136,200$2,443,428-10,000-6.84%$17.9413F
UANCVR PARTNERS LP0.97%12,496$1,126,140-2,504-16.69%$90.1213F
GELGENESIS ENERGY L P0.9%62,000$1,036,020-12,000-16.22%$16.7113F
SITCSITE CTRS CORP0.11%14,000$126,140-26,001-65%$9.0113F
AMPYAMPLIFY ENERGY CORP NEW0.05%10,000$52,500-270,000-96.43%$5.2513F
CABACABALETTA BIO INC0.02%11,300$26,442-4,700-29.38%$2.3413F